BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23546539)

  • 1. PTEN expression and suppression of proliferation are associated with Cdx2 overexpression in gastric cancer cells.
    Bai ZG; Ye YJ; Shen DH; Lu YY; Zhang ZT; Wang S
    Int J Oncol; 2013 May; 42(5):1682-91. PubMed ID: 23546539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDX2 inhibits invasion and migration of gastric cancer cells by phosphatase and tensin homologue deleted from chromosome 10/Akt signaling pathway.
    Liu YQ; Bai ZG; Ma XM; Zhang ZT
    Chin Med J (Engl); 2015 Apr; 128(8):1065-71. PubMed ID: 25881601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase activity of nuclear PTEN is required for CDX2-mediated intestinal differentiation of gastric carcinoma.
    Semba S; Satake S; Matsushita M; Yokozaki H
    Cancer Lett; 2009 Feb; 274(1):143-50. PubMed ID: 18996641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
    Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
    APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR-7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway.
    Pan H; Li T; Jiang Y; Pan C; Ding Y; Huang Z; Yu H; Kong D
    J Cell Biochem; 2018 Jan; 119(1):440-446. PubMed ID: 28608528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway.
    Guo JQ; Li SJ; Guo GX
    Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
    Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
    Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-9 downregulates CDX2 expression in gastric cancer cells.
    Rotkrua P; Akiyama Y; Hashimoto Y; Otsubo T; Yuasa Y
    Int J Cancer; 2011 Dec; 129(11):2611-20. PubMed ID: 21225631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN.
    Wang S; Tie J; Wang R; Hu F; Gao L; Wang W; Wang L; Li Z; Hu S; Tang S; Li M; Wang X; Nie Y; Wu K; Fan D
    Cancer Lett; 2015 Mar; 358(2):210-219. PubMed ID: 25543086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Hu M; Zhu S; Xiong S; Xue X; Zhou X
    Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter.
    Gan L; Xu M; Hua R; Tan C; Zhang J; Gong Y; Wu Z; Weng W; Sheng W; Guo W
    J Hematol Oncol; 2018 Jan; 11(1):9. PubMed ID: 29335012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
    Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
    Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
    Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab.
    Eto K; Iwatsuki M; Watanabe M; Ida S; Ishimoto T; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Ann Surg Oncol; 2014 Jan; 21(1):343-50. PubMed ID: 24154840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.